A detailed history of Two Sigma Investments, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 17,072 shares of ABBV stock, worth $3.33 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,072
Previous 677,654 97.48%
Holding current value
$3.33 Million
Previous $123 Million 97.63%
% of portfolio
0.01%
Previous 0.31%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $102 Million - $119 Million
-660,582 Reduced 97.48%
17,072 $2.93 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $26.2 Million - $29.9 Million
-164,027 Reduced 19.49%
677,654 $123 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $8.6 Million - $9.69 Million
-62,510 Reduced 6.91%
841,681 $130 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $125 Million - $144 Million
-932,692 Reduced 50.78%
904,191 $135 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $159 Million - $198 Million
1,203,543 Added 190.03%
1,836,883 $247 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $66.7 Million - $76.8 Million
460,920 Added 267.32%
633,340 $101 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $23.8 Million - $28.6 Million
172,420 New
172,420 $27.9 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $124 Million - $158 Million
-900,337 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $135 Million - $168 Million
-1,025,909 Reduced 53.26%
900,337 $146 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $114 Million - $144 Million
1,057,631 Added 121.76%
1,926,246 $261 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $132 Million - $150 Million
-1,242,706 Reduced 58.86%
868,615 $93.7 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $30.4 Million - $33.9 Million
-288,876 Reduced 12.04%
2,111,321 $238 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $3.74 Million - $4.12 Million
36,559 Added 1.55%
2,400,197 $260 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $39.9 Million - $53.8 Million
-495,317 Reduced 17.33%
2,363,638 $253 Million
Q3 2020

Nov 16, 2020

BUY
$85.91 - $100.83 $91.9 Million - $108 Million
1,069,700 Added 59.78%
2,858,955 $250 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $40.5 Million - $54.2 Million
551,553 Added 44.56%
1,789,255 $176 Million
Q1 2020

May 15, 2020

BUY
$64.5 - $97.79 $13.1 Million - $19.8 Million
202,928 Added 19.61%
1,237,702 $94.3 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $96.7 Million - $121 Million
-1,340,930 Reduced 56.44%
1,034,774 $91.6 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $29.3 Million - $35.2 Million
464,722 Added 24.32%
2,375,704 $180 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $25.1 Million - $32.1 Million
-382,634 Reduced 16.68%
1,910,982 $139 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $176 Million - $207 Million
2,282,042 Added 19716.97%
2,293,616 $185 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $11.3 Million - $13.9 Million
-144,726 Reduced 92.6%
11,574 $1.07 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $13.9 Million - $15.4 Million
156,300 New
156,300 $14.8 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $98.2 Million - $116 Million
-1,094,295 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $88.8 Million - $119 Million
964,581 Added 743.62%
1,094,295 $104 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $2.02 Million - $2.22 Million
-22,571 Reduced 14.82%
129,714 $12.5 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $10.6 Million - $13.6 Million
152,285
152,285 $13.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.